SALT LAKE CITY, Jan. 21, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, announced a study revealing that more patients completed ...
Myriad Genetics, Inc. announced a study indicating that the use of its online screening tool, MyGeneHistory®, alongside a virtual education program, significantly increased the completion rates for ...
Australian researchers are launching a landmark study to identify the genetic cause of multiple sclerosis (MS). MS impacts more than 33,000 people in Australia however the exact cause of the disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback